Demand of Metastatic Melanoma : Pipeline Review, Technology, Applications, Growth and Status 2017
ResearchMoz presents professional and in-depth study of "Metastatic Melanoma - Pipeline Review, H1 2015".
Global Markets Directs, Metastatic Melanoma Pipeline Review, H1 2015, provides an overview of the Metastatic Melanomas therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Metastatic Melanoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Melanoma and special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides a snapshot of the global therapeutic landscape of Metastatic Melanoma
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Metastatic Melanoma and enlists all their major and minor projects
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=245098
The report summarizes all the dormant and discontinued pipeline projects
A review of the Metastatic Melanoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Metastatic Melanoma pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products
Table of Contents
Introduction 11
Global Markets Direct Report Coverage 11
Metastatic Melanoma Overview 12
Therapeutics Development 13
Pipeline Products for Metastatic Melanoma - Overview 13
Pipeline Products for Metastatic Melanoma - Comparative Analysis 14
Metastatic Melanoma - Therapeutics under Development by Companies 15
Metastatic Melanoma - Therapeutics under Investigation by Universities/Institutes 22
Metastatic Melanoma - Pipeline Products Glance 24
Late Stage Products 24
Clinical Stage Products 25
Early Stage Products 26
Metastatic Melanoma - Products under Development by Companies 27
Metastatic Melanoma - Products under Investigation by Universities/Institutes 35
Metastatic Melanoma - Companies Involved in Therapeutics Development 36
AB Science 36
AbbVie Inc. 37
Adaptimmune Limited 38
Affichem 39
Agalimmune Ltd 40
Agenus, Inc. 41
Altor BioScience Corporation 42
Amgen Inc. 43
Astex Pharmaceuticals, Inc. 44
AstraZeneca PLC 45
AVAX Technologies, Inc. 46
Bayer AG 47
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=245098
Bioncotech Therapeutics S.L. 48
Bionomics Limited 49
Boehringer Ingelheim GmbH 50
Bristol-Myers Squibb Company 51
Cancer Therapeutics CRC Pty Ltd 52
Cavion LLC 53
Celgene Corporation 54
Celldex Therapeutics, Inc. 55
Colby Pharmaceutical Company 56
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/
Global Markets Directs, Metastatic Melanoma Pipeline Review, H1 2015, provides an overview of the Metastatic Melanomas therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Metastatic Melanoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Melanoma and special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides a snapshot of the global therapeutic landscape of Metastatic Melanoma
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Metastatic Melanoma and enlists all their major and minor projects
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=245098
The report summarizes all the dormant and discontinued pipeline projects
A review of the Metastatic Melanoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Metastatic Melanoma pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products
Table of Contents
Introduction 11
Global Markets Direct Report Coverage 11
Metastatic Melanoma Overview 12
Therapeutics Development 13
Pipeline Products for Metastatic Melanoma - Overview 13
Pipeline Products for Metastatic Melanoma - Comparative Analysis 14
Metastatic Melanoma - Therapeutics under Development by Companies 15
Metastatic Melanoma - Therapeutics under Investigation by Universities/Institutes 22
Metastatic Melanoma - Pipeline Products Glance 24
Late Stage Products 24
Clinical Stage Products 25
Early Stage Products 26
Metastatic Melanoma - Products under Development by Companies 27
Metastatic Melanoma - Products under Investigation by Universities/Institutes 35
Metastatic Melanoma - Companies Involved in Therapeutics Development 36
AB Science 36
AbbVie Inc. 37
Adaptimmune Limited 38
Affichem 39
Agalimmune Ltd 40
Agenus, Inc. 41
Altor BioScience Corporation 42
Amgen Inc. 43
Astex Pharmaceuticals, Inc. 44
AstraZeneca PLC 45
AVAX Technologies, Inc. 46
Bayer AG 47
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=245098
Bioncotech Therapeutics S.L. 48
Bionomics Limited 49
Boehringer Ingelheim GmbH 50
Bristol-Myers Squibb Company 51
Cancer Therapeutics CRC Pty Ltd 52
Cavion LLC 53
Celgene Corporation 54
Celldex Therapeutics, Inc. 55
Colby Pharmaceutical Company 56
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/
Comments
Post a Comment